Rising Prevalence and Patient Demographics in England
Over a 15-year span from 2008 to 2022, the prevalence of the condition grew by more than 50 percent. Data gathered from hospital and primary care records linked with deprivation, ethnicity, and mortality information showed that prevalence moved from 20.9 per million in 2008 up to 32.5 per million by 2022. Meanwhile, incidence held steady until 2016 before climbing to reach 4.9 per million person-years.
Out of 25.8 million individuals examined in the research, investigators identified 991 patients suffering from the condition. Among those diagnosed, 63 percent were female. Breakdown by ethnicity indicated that 86 percent were White, 10 percent were Asian, and 3 percent belonged to Black, Mixed, or Other backgrounds. The mean age for the onset of the condition stood at 51.4 years, though Asian patients experienced onset earlier than White patients. Globally, historical data notes that the condition can present at any age from childhood onward, with a median diagnosis age around 50 years.
Mortality Risks and Reduced Life Expectancy
The investigation revealed that individuals diagnosed with the condition faced substantially higher all-cause mortality risk and a reduced life expectancy compared to people without the illness. Specifically, patients carried more than three times the risk of all-cause mortality. Elevated death rates were also documented for circulatory, digestive, respiratory diseases, and neoplasms. The most pronounced association involved sepsis, where the risk of mortality climbed substantially higher for affected patients. Researchers also noted that younger ages at the time of diagnosis correlated with the greatest reduction in expected lifespan.
Study authors emphasized that the observational design highlights associations rather than proving direct causation between the condition and the reported mortality outcomes. Nevertheless, the findings offer vital population-level insights into the mortality burden and epidemiology of the illness, underlining the necessity for targeted approaches aimed at decreasing preventable illness and death.